View in EDS HTML Full Text PDF Full Text

Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.

Saved in:
Bibliographic Details
Title: Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.
Authors: Castagnoli L; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Franceschini A; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Cancila V; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy., Dugo M; Breast Cancer Unit Clinical Translational and Immunotherapy Research, Department of Medical Oncology, IRCCS Ospedale San Rafaele, Milan, Italy., Bigliardi M; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Toneguzzo P; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Regondi V; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Corsetto PA; Department of Pharmacologicaland, Biomolecular Sciences 'Rodolfo Paoletti',, Università Di Milano, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Mazzucchelli S; Department of Biomedical and Clinical Sciences, Università Di Milano, Milan, Italy., Corsi F; Surgery Department, Istituti Clinici Scientifci Maugeri IRCCS, Pavia, Italy., Belfiore A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Vingiani A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy., Pruneri G; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy., Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Tagliabue E; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Vernieri C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Triulzi T; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Pupa SM; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy. Serenella.Pupa@istitutotumori.mi.it.
Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 May 30; Vol. 44 (1), pp. 165. Date of Electronic Publication: 2025 May 30.
Publication Type: Published Erratum
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40442724
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Castagnoli+L%22">Castagnoli L</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Franceschini+A%22">Franceschini A</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cancila+V%22">Cancila V</searchLink>; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Dugo+M%22">Dugo M</searchLink>; Breast Cancer Unit Clinical Translational and Immunotherapy Research, Department of Medical Oncology, IRCCS Ospedale San Rafaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bigliardi+M%22">Bigliardi M</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Chiodoni+C%22">Chiodoni C</searchLink>; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Toneguzzo+P%22">Toneguzzo P</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Regondi+V%22">Regondi V</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Corsetto+PA%22">Corsetto PA</searchLink>; Department of Pharmacologicaland, Biomolecular Sciences 'Rodolfo Paoletti',, Università Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pietrantonio+F%22">Pietrantonio F</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mazzucchelli+S%22">Mazzucchelli S</searchLink>; Department of Biomedical and Clinical Sciences, Università Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Corsi+F%22">Corsi F</searchLink>; Surgery Department, Istituti Clinici Scientifci Maugeri IRCCS, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Belfiore+A%22">Belfiore A</searchLink>; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Vingiani+A%22">Vingiani A</searchLink>; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pruneri+G%22">Pruneri G</searchLink>; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ligorio+F%22">Ligorio F</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+MP%22">Colombo MP</searchLink>; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tagliabue+E%22">Tagliabue E</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tripodo+C%22">Tripodo C</searchLink>; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Vernieri+C%22">Vernieri C</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Triulzi+T%22">Triulzi T</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pupa+SM%22">Pupa SM</searchLink>; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy. Serenella.Pupa@istitutotumori.mi.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228308647%22">Journal of experimental & clinical cancer research : CR</searchLink> [J Exp Clin Cancer Res] 2025 May 30; Vol. 44 (1), pp. 165. <i>Date of Electronic Publication: </i>2025 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8308647 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-9966 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203929078%22">03929078 </searchLink><i>NLM ISO Abbreviation: </i>J Exp Clin Cancer Res <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40442724
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13046-025-03426-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 165
    Titles:
      – TitleFull: Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Castagnoli L
      – PersonEntity:
          Name:
            NameFull: Franceschini A
      – PersonEntity:
          Name:
            NameFull: Cancila V
      – PersonEntity:
          Name:
            NameFull: Dugo M
      – PersonEntity:
          Name:
            NameFull: Bigliardi M
      – PersonEntity:
          Name:
            NameFull: Chiodoni C
      – PersonEntity:
          Name:
            NameFull: Toneguzzo P
      – PersonEntity:
          Name:
            NameFull: Regondi V
      – PersonEntity:
          Name:
            NameFull: Corsetto PA
      – PersonEntity:
          Name:
            NameFull: Pietrantonio F
      – PersonEntity:
          Name:
            NameFull: Mazzucchelli S
      – PersonEntity:
          Name:
            NameFull: Corsi F
      – PersonEntity:
          Name:
            NameFull: Belfiore A
      – PersonEntity:
          Name:
            NameFull: Vingiani A
      – PersonEntity:
          Name:
            NameFull: Pruneri G
      – PersonEntity:
          Name:
            NameFull: Ligorio F
      – PersonEntity:
          Name:
            NameFull: Colombo MP
      – PersonEntity:
          Name:
            NameFull: Tagliabue E
      – PersonEntity:
          Name:
            NameFull: Tripodo C
      – PersonEntity:
          Name:
            NameFull: Vernieri C
      – PersonEntity:
          Name:
            NameFull: Triulzi T
      – PersonEntity:
          Name:
            NameFull: Pupa SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 05
              Text: 2025 May 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1756-9966
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of experimental & clinical cancer research : CR
              Type: main
ResultId 1